Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.72m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Interim Results

21 Oct 2005 17:07

Castor Investments Plc21 October 2005 Castor Investments plc (the "Company") 21 October 2005 INTERIM REPORT TO SHAREHOLDERS Chairman's statement I have pleasure in presenting the first set of Interim Results for CastorInvestments Plc ("Castor" or "the Company") for the period from incorporation on31st January 2005 to 31st July 2005. Castor generated a trading loss for theperiod of £78,000, primarily due to expenses of admission and had cash balancesof £982,000 remaining at 31 July 2005. During this period your Board has been actively identifying and examiningpotential acquisitions for Castor in accordance with the Company's remit as setout in its AIM Admission Document. Your Board has considered a wide range of potential investment opportunities andthey have been pleased with the quantity and quality of this deal flow. None ofthese potential acquisitions has yet reached the exacting standards set by yourBoard. The Board has intensified their search in identifying a suitable company inwhich to invest and feel confident this will lead to an acquisition in the nearfuture. David BartonNon-Executive Chairman Enquiries: Castor Investments PlcDavid Barton (Chairman) Tel: 020 7584 9256 Teather & Greenwood LtdStephen Austin and Harry Nicholas Tel: 020 7426 9000 CASTOR INVESTMENTS PLCInterim Unaudited Accounts for the Six Months ended 31 July 2005 PROFIT AND LOSS ACCOUNT Half year ended 31 July 2005 (Unaudited) £000 Administrative expenses 95 Operating Loss (95) Interest received 17 Loss on ordinary activities before and after taxation (78) Loss per ordinary share (pence) (Note 2)Basic (0.3)Diluted (0.3) All amounts relate to continuing activities. All recognised gains and losses are shown in the Profit & Loss Account. RECONCILIATION OF MOVEMENT IN SHAREHOLDERS FUNDS Half year ended 31 July 2005 (Unaudited) £000 Loss for the period (78) New share capital subscribed Share premium 272 Opening shareholders' funds 788 Closing shareholders' funds 982 CASTOR INVESTMENTS PLCInterim Unaudited Accounts for the Six Months ended 31 July 2005 BALANCE SHEET 31 July 2005 (Unaudited) £000 Current Assets Cash at bank and in hand 982 982 Capital and ReservesCalled up share capital 272Share premium 788Profit and loss account deficit (78) Shareholders' funds - equity 982 CASTOR INVESTMENTS PLCInterim Unaudited Accounts for the Six Months ended 31 July 2005 CASH FLOW STATEMENT Half year ended 31 July 2005 (Unaudited) £000 Net loss from operating activities (78) Cash outflow before financing (78) FinancingIssues of ordinary shares for cash 1,060 Increase/(decrease) in cash 982 CASTOR INVESTMENTS PLCInterim Unaudited Accounts for the Six Months ended 31 July 2005 Note 1 - Basis of preparation The interim accounts have been prepared in accordance with applicable accountingstandards and under the historic cost convention. The financial information set out in this interim statement, does not constitutestatutory accounts within the meaning of Section 240 of the Companies Act 1985. Note 2 - Loss per share The loss per share is calculated based on: Half year ended 31 July 2005 Loss for the period (£000) (78) Weighted average number of shares in issue (000) 27,200 END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh
31st Oct 20177:00 amRNSNotice of Results
25th Oct 20177:00 amRNSAppointment of Joint Broker
5th Oct 20177:00 amRNSFurther significant fund realisation achieved
3rd Oct 20177:00 amRNSWebsite launch
20th Sep 20177:00 amRNS£3.1million syndicated investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.